Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Damien, Reita"'
Autor:
Larysa Benistant, Damien Reita, Maleka Schenck, Vincent Castelain, Hélène Cebula, Benoît Lhermitte, Laura Bender
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 11, Pp 3037-3041 (2024)
Abstract Diffuse midline gliomas present a particularly intricate and challenging clinical scenario. This rare case involves a patient with comutant H3F3A and FGFR diffuse midline glioma with a clinical presentation of fulminant leptomeningitis. A 22
Externí odkaz:
https://doaj.org/article/2931e7a86ede40d0912b2c90aa58b40b
Autor:
Juliette Simon, Damien Reita, Eric Guerin, Benoit Lhermitte, Noelle Weingertner, François Lefebvre, Marie Karanian, Julien Masliah-Planchon, Veronique Lindner, Alina Onea, Sarah Jannier, Alexandra Salmon, Guillaume Bergthold, Florence Vincent, Marlène Deschuyter, Marie-Odile Barbaza, Natacha Entz-Werlé
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Introduction Faced to the growing development of collecting systematic molecular analyses in relapsed pediatric cancers to transform their targeted matched therapies, this study aimed to assess the clinical and therapeutic indications of sys
Externí odkaz:
https://doaj.org/article/fd4aae2496a942ca8d74a1c96e7ff44d
Autor:
Thibaut Wolf, Andres Hugo Coca, Noelle Weingertner, Marie Pierre Chenard, Alexandra Meurgey, Damien Reita, Erwan Pencreach, Pascale Varlet, Natacha Entz-Werlé, Benoît Lhermitte
Publikováno v:
Virchows Archiv : an international journal of pathology.
Primary intracranial sarcoma DICER1-mutant is a rare and newly recognized tumor type introduced in the 2021 WHO Classification of Central Nervous System Tumors. It is defined as a spindle cell sarcoma dysplaying eosinophilic intracytoplasmic globules
Publikováno v:
International Journal of Molecular Sciences. 24:9137
Tumor metabolism is emerging as a potential target for cancer therapies. This new approach holds particular promise for the treatment of glioblastoma, a highly lethal brain tumor that is resistant to conventional treatments, for which improving thera
Autor:
Saidu Sani, Nikita Pallaoro, Mélissa Messe, Chloé Bernhard, Nelly Etienne-Selloum, Horst Kessler, Luciana Marinelli, Natacha Entz-Werle, Sophie Foppolo, Sophie Martin, Damien Reita, Monique Dontenwill
Publikováno v:
Cancers, Vol 14, Iss 369, p 369 (2022)
Cancers; Volume 14; Issue 2; Pages: 369
Cancers
Cancers; Volume 14; Issue 2; Pages: 369
Cancers
Simple Summary Glioblastomas are the deadliest brain tumours. The standard of care associates surgery, radio- and chemotherapy with Temozolomide as the reference drug. Despite this treatment, most of the tumours recur. The characterization of resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade05d13a586e74a91c1f978d9dcce55
http://hdl.handle.net/11588/877408
http://hdl.handle.net/11588/877408
Autor:
Lucas Geyer, Thibaut Wolf, Marie-Pierre Chenard, Helene Cebula, Roland Schott, Georges Noel, Eric Guerin, Erwan Pencreach, Damien Reita, Natacha Entz-Werlé, Benoît Lhermitte
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1512
Volume 15
Issue 5
Pages: 1512
CDKN2A is a tumor suppressor gene encoding the p16 protein, a key regulator of the cell cycle. CDKN2A homozygous deletion is a central prognostic factor for numerous tumors and can be detected by several techniques. This study aims to evaluate the ex
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
Autor:
Benoit Lhermitte, Thibaut Wolf, Marie Pierre Chenard, Andres Coca, Julien Todeschi, François Proust, Edouard Hirsch, Roland Schott, Georges Noel, Eric Guerin, Damien Reita, Agathe Chammas, Alexandra Salmon, Sophie Martin, Monique Dontenwill, Natacha Entz-Werlé
Publikováno v:
Cancers. 15:1268
Over the last few decades, deciphering the alteration of molecular pathways in brain tumors has led to impressive changes in diagnostic refinement. Among the molecular abnormalities triggering and/or driving gliomas, alterations in the MAPK pathway r
Autor:
Damien, Reita, Lucile, Pabst, Erwan, Pencreach, Eric, Guérin, Laurent, Dano, Valérie, Rimelen, Anne-Claire, Voegeli, Laurent, Vallat, Céline, Mascaux, Michèle, Beau-Faller
Publikováno v:
Cancers. 14(5)
KRAS is the most frequently mutated oncogene in non-small cell lung cancers (NSCLC), with a frequency of around 30%, and encoding a GTPAse that cycles between active form (GTP-bound) to inactive form (GDP-bound). The
Autor:
Damien, Reita, Lucile, Pabst, Erwan, Pencreach, Eric, Guérin, Laurent, Dano, Valérie, Rimelen, Anne-Claire, Voegeli, Laurent, Vallat, Céline, Mascaux, Michèle, Beau-Faller
Publikováno v:
Cancers
Simple Summary Non-small cell lung cancer (NSCLC) is the most common cancer in the world. For common EGFR mutations, treatment is based on different inhibitors. Despite the excellent disease control with inhibitors, acquired resistance inevitably occ
Autor:
Marie Courant, Benoit Lhermitte, Eric Guerin, Agathe Chammas, Damien Reita, Consuelo Sebastia, Valérie Douzal, Flaviu Gabor, Alexandra Salmon, Julien Todeschi, Andres Hugo Coca, Florence Vincent, Natacha Entz-Werlé
Publikováno v:
Neuro-Oncology. 24:i91-i91
Pediatric low-grade gliomas (PLGG) are the most common brain tumors diagnosed during childhood and represent a heterogeneous group associating variable molecular abnormalities. To go further and develop specific statistical patterns integrating altog